Intersect ENT Financials
| XENTDelisted Stock | USD 28.24 0.00 0.00% |
With this module, you can analyze Intersect financials for your investing period. You should be able to track the changes in Intersect ENT individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Intersect |
Understanding current and past Intersect ENT Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Intersect ENT's financial statements are interrelated, with each one affecting the others. For example, an increase in Intersect ENT's assets may result in an increase in income on the income statement.
The data published in Intersect ENT's official financial statements usually reflect Intersect ENT's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Intersect ENT. For example, before you start analyzing numbers published by Intersect accountants, it's critical to develop an understanding of what Intersect ENT's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Intersect ENT's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Intersect ENT's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Intersect ENT's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Intersect ENT. Please utilize our Beneish M Score to check the likelihood of Intersect ENT's management manipulating its earnings.
Intersect ENT Stock Summary
Intersect ENT competes with Comstock Holding, Employers Holdings, QBE Insurance, Direct Line, and NMI Holdings. Intersect ENT, Inc. operates as an ear, nose, and throat medical technology company in the United States. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California. Intersect Ent operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 406 people.| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US46071F1030 |
| Business Address | 1555 Adams Drive, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | NYSE Composite |
| Website | www.intersectent.com |
| Phone | 650 641 2100 |
| Currency | USD - US Dollar |
You should never invest in Intersect ENT without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Intersect Stock, because this is throwing your money away. Analyzing the key information contained in Intersect ENT's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Intersect ENT Key Financial Ratios
Generally speaking, Intersect ENT's financial ratios allow both analysts and investors to convert raw data from Intersect ENT's financial statements into concise, actionable information that can be used to evaluate the performance of Intersect ENT over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Intersect ENT reports annually and quarterly.Intersect Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Intersect ENT's current stock value. Our valuation model uses many indicators to compare Intersect ENT value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Intersect ENT competition to find correlations between indicators driving Intersect ENT's intrinsic value. More Info.Intersect ENT is rated first in return on equity category among related companies. It is rated first in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Intersect ENT by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Intersect ENT's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Intersect ENT's earnings, one of the primary drivers of an investment's value.Intersect ENT Market Pulse
| Quote | 28.24 |
| Change(%) | 0.00 |
| Change | 0.00 |
| Open | 28.24 |
| Low | 28.24 |
| High | 28.24 |
| Volume | 0 |
| Exchange | NASDAQ |
About Intersect ENT Financials
What exactly are Intersect ENT Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Intersect ENT's income statement, its balance sheet, and the statement of cash flows. Potential Intersect ENT investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Intersect ENT investors may use each financial statement separately, they are all related. The changes in Intersect ENT's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Intersect ENT's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Intersect ENT Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Intersect ENT is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Intersect has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Intersect ENT's financials are consistent with your investment objective using the following steps:- Review Intersect ENT's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Intersect ENT's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Intersect ENT's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Intersect ENT's stock is overvalued or undervalued.
Intersect ENT April 16, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Intersect ENT help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Intersect ENT. We use our internally-developed statistical techniques to arrive at the intrinsic value of Intersect ENT based on widely used predictive technical indicators. In general, we focus on analyzing Intersect Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Intersect ENT's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.4172 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 1.73 | |||
| Value At Risk | (0.39) | |||
| Potential Upside | 0.9865 |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Intersect Stock
If you are still planning to invest in Intersect ENT check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intersect ENT's history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |